GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Check-Cap Ltd (NAS:CHEK) » Definitions » Shiller PE Ratio

Check-Cap (Check-Cap) Shiller PE Ratio : (As of May. 15, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Check-Cap Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Check-Cap Shiller PE Ratio Historical Data

The historical data trend for Check-Cap's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Check-Cap Shiller PE Ratio Chart

Check-Cap Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Check-Cap Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Check-Cap's Shiller PE Ratio

For the Diagnostics & Research subindustry, Check-Cap's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Check-Cap's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Check-Cap's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Check-Cap's Shiller PE Ratio falls into.



Check-Cap Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Check-Cap's E10 for the quarter that ended in Sep. 2023 is calculated as:

For example, Check-Cap's adjusted earnings per share data for the three months ended in Sep. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.44/129.8595*129.8595
=-0.440

Current CPI (Sep. 2023) = 129.8595.

Check-Cap Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201312 0.000 98.326 0.000
201403 -43.728 99.695 -56.959
201406 -45.941 100.560 -59.327
201409 -11.747 100.428 -15.190
201412 -0.947 99.070 -1.241
201503 -124.800 99.621 -162.681
201506 -43.200 100.684 -55.718
201509 -55.200 100.392 -71.403
201512 -52.800 99.792 -68.708
201603 -50.400 100.470 -65.143
201606 -36.000 101.688 -45.973
201609 -112.800 101.861 -143.805
201612 -36.000 101.863 -45.895
201703 38.800 102.862 48.983
201706 -40.400 103.349 -50.763
201709 -27.600 104.136 -34.418
201712 -24.400 104.011 -30.464
201803 -25.400 105.290 -31.327
201806 -14.000 106.317 -17.100
201809 -10.000 106.507 -12.193
201812 -11.600 105.998 -14.211
201903 -8.800 107.251 -10.655
201906 -8.200 108.070 -9.853
201909 -8.400 108.329 -10.069
201912 -9.200 108.420 -11.019
202003 -6.800 108.902 -8.109
202006 -2.400 108.767 -2.865
202009 -1.800 109.815 -2.129
202012 -1.600 109.897 -1.891
202103 -1.000 111.754 -1.162
202106 -1.200 114.631 -1.359
202109 -0.800 115.734 -0.898
202112 -1.200 117.630 -1.325
202203 -1.130 121.301 -1.210
202206 -0.820 125.017 -0.852
202209 -0.810 125.227 -0.840
202212 -0.635 125.222 -0.659
202303 -0.760 127.348 -0.775
202306 -1.180 128.729 -1.190
202309 -0.440 129.860 -0.440

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Check-Cap  (NAS:CHEK) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Check-Cap Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Check-Cap's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Check-Cap (Check-Cap) Business Description

Traded in Other Exchanges
Address
29 Abba Hushi Avenue, Check-Cap Building, P.O. Box 1271, Isfiya, ISR, 3009000
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.